USANA Health Sciences, Inc. announced its financial results for the fiscal first quarter ended March 29, 2025. Consolidated net sales increased by 10% year-over-year to $250 million, primarily driven by the newly acquired Hiya business. Net earnings attributable to USANA decreased by 43% to $9.4 million, resulting in diluted EPS of $0.49.
Hiya Health contributed $37 million in net sales during the quarter and reported 224,000 active monthly subscribers, demonstrating strong growth momentum. The direct selling business showed modest sequential growth in net sales and active customers for the second consecutive quarter.
The company reiterated its full-year fiscal 2025 outlook, projecting consolidated net sales between $920 million and $1.0 billion, and adjusted diluted EPS between $2.35 and $3.00. USANA ended the quarter with $180 million in cash and cash equivalents and $23 million of debt, having repurchased 399,000 shares for $12 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.